Time: Mar 13 - Mar 14
Location:
Senate House, London UK
Hear Dr Miriam V. Dwek, University of Westminster (Senior Lecturer in Biochemistry) present results on evaluating lectin-cancer cell interactions the Attana Cell biosensor in which binding events take place at the cell surface, more closely mimicking an in vivo system.
Nov 16, 2011 09:32 EST One efficient tool in the selection process is biochemical label‐free kinetic characterisation of interactions between candidate and target molecules. Information on association and dissociation rates and affinity is provided under purified conditions. However, the results obtained are often different compared to the affinity results obtained with cell based methods.
Dec 22, 2010 03:00 EST Attana is one of the sponsor companies at the upcoming marcus evans Discovery Summit 2011 in Cannes, France, 21-23 March. Prior to the event marcus evans and Aastrup discuss in this interview the role biologics can play in speeding up drug discovery and subsequent stages.
Nov 03, 2011 12:05 EDT Promoting our biosensors all over the world involve fun travelling performing LIVE demos, seminars, customer meetings and training. Coming back from one of our longer trips recently we discovered that the biotech field is just as hot as the fashion industry.
Dec 01, 2010 10:07 EST Recently a film crew visited the Attana office to prepare our participation on Terry Bradshaw’s “Today in America” show. Their research team had heard about our ground breaking cell based biosensor and asked us to participate on the show. The days before the filming were filled with intense preparation, and consequently on the day of shooting everything went smoothly..
Jun 02, 2010 09:14 EDT The Attana Cell 200 enables kinetic characterization of interactions on intact cells, in real time. Cells can be cultivated directly on Attana’s proprietary cell surface or captured from cell suspension before analysis.
Jan 14, 2011 03:00 EST
Attana Cell 200 biosensor has the unique ability to determine label-free kinetics directly on the cell surface, therefore disclosing the full complexity of the interaction at a very early stage. By delivering biologically relevant information this early in the research process, the Attana Cell 200 minimizes costs and increases success during clinical trials. (produced by TTV AB)
Length 1:24
Add commentThe comment was saved
Prior to publication, it must be approved by Attana AB.